You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. ShH10-Mediated Long-Term Delivery of Neurotrophic Factors in Animal Models of Gla

    SBC: AVALANCHE BIOTECHNOLOGIES, INC.            Topic: NEI

    DESCRIPTION (provided by applicant): The objective of this proposal is to examine the efficacy of a novel adeno-associated virus (AAV) variant, ShH10, expressing neurotrophic factors for the treatment of glaucoma. Glaucoma is the second leading cause of blindness with high associated societal costs, and is expected to grow. The hallmark of glaucoma is retinal ganglion cell (RGC) death, which leads ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  2. Rapid intercalator removal from size-selected DNA for next generation sequencing

    SBC: DIFFINITY GENOMICS, INC.            Topic: NHGRI

    DESCRIPTION (provided by applicant): Information from next generation sequencing is widely used in translational studies and promises to be a cornerstone of personalized medicine where therapeutic courses are linked to an individual's genetic makeup. Extraction of DNA from gels following electrophoresis to obtain size-selected DNA fragments is a labor intensive part of library preparation ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  3. Suv39H Targeted Therapy for Treatment of Childhood Rhabdomyosarcoma

    SBC: BUFFALO BIOLABS, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): Rhabdomyosarcoma (RMS) is a childhood malignant tumor and is thought to arise due to the arrest of skeletal muscle differentiation (myogenesis) program. It accounts for 3.5% of all malignancies in children. Despite multimodality therapeutic treatment approaches, the outlook for patients with metastatic subtype, alveolar rhabdomyosarcoma (ARMS), remains unchange ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Developing an online educational curriculum to enhance parent-supervised driving

    SBC: Parallel Consulting, LLC            Topic: NICHD

    DESCRIPTION (provided by applicant): Motor vehicle crashes are the leading cause of death and injury for teens, accounting annually for over 3000 deaths, 100 times as many injuries, and over 14 billion dollars in associated costs. The CDC has identified traffic crashes and associated injuries as a top public health priority. Inexperience is the leading cause of crashes among novice teen drivers, b ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Development of a diagnostic biomarker for Ewing's Sarcoma family of tumors.

    SBC: Entrogen, Inc.            Topic: NCI

    DESCRIPTION (provided by applicant): Development of a diagnostic biomarker for Ewing's Sarcoma family of tumors Ewing's family tumors (EFTs) are characterized by recurrent chromosomal translocations that produce chimeric fusions between the EWS gene and one of five ETS transcription factors. The expression of EWS/FLI1, the predominant fusion product in EFTs, is believed to deregulate do ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Advanced Assessment to Accelerate Diagnostic Skill Acquisition

    SBC: Parallel Consulting, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): Current approaches to medical education produce new physicians with insufficient clinical competency to practice effectively with limited supervision, which has serious implications for patient outcomes during hospitaloff hours. Up to 70% of patients admitted to a hospital are admitted on nights or weekends, when staffing is low and residents may be in charge o ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Recyclable Magnetic Co/C Hybrid ROMP Reagents, Scavengers and Ligands

    SBC: MATERIA, INC.            Topic: NIGMS

    DESCRIPTION (provided by applicant): This Fast Track Small Business Technology Transfer study between Materia, Inc. in Pasadena, CA and the University of Kansas intends to build upon successes of our current Phase II Fast Track STTR grant (1R42GM097896-03)which ends on March 30, 2014. Preliminary results serve as a solid foundation for this Fast Track submission entitled Development of Recyclable ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Perceptually Accurate Video Manipulation of Vehicle Speed for Teen Driver Training

    SBC: Parallel Consulting, LLC            Topic: NICHD

    ? DESCRIPTION (provided by applicant): Motor vehicle crashes are the leading cause of death and injury for teens, accounting annually for over 3000 deaths, 100 times as many injuries, and over 14 billion dollars in associated costs. Speeding contributes to more than 30% of teen driving crashes and is the primary factor in over 20% of serious teen crashes. Among teens, driving too fast for cond ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Redesign of the Carbapenem Scaffold

    SBC: THERAVANCE, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Carbapenemase-producing bacteria now threaten to undermine the efficacy of the carbapenems, long considered to be the most potent and reliable of the -lactam antibiotics. In Gram-negative microorganisms, in particular,the ability to produce class A serine carbapenemases, such as the plasmid-mediated KPC enzymes, or class B metallo-carbapenemases, such as the ND ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. ASC101 Enhancement of Regenerative Capacity of Amniotic Fluid-derived Stem Cells

    SBC: TARGAZYME, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): In the present STTR we propose to investigate two novel approaches in our exploration of the therapeutic and regenerative potential of cell-based medicine. Furthermore, we will utilize a preclinical animal model of compression syndrome (CS) that mimics the pathophysiology of multiple injuries such as crush injuries, burns, circulation blockage, fractures, hemor ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government